Latest Financial Strategy News

ASX has suspended trading of Magnum Mining’s MGUN securities following the abrupt cancellation of its entitlement offer, raising questions about the company’s capital strategy.

Otto Energy Limited has announced a special unfranked dividend of AUD 0.00143 per ordinary share, with key dates set for late May and mid-June 2025.

Lykos Metals announces key leadership changes with David Wheeler stepping up as Non-Executive Chair and Petar Tomasevic taking the helm as Interim CEO, signaling a strategic pivot as the company advances in the Balkan region.

Alice Queen Limited has lifted its trading suspension following the announcement of a proposed capital raise, signaling a pivotal moment for the company’s financial strategy.

Epsilon Healthcare has launched a $1 million loan note issue aimed at supporting its working capital and diversification efforts, with a 10% interest rate and potential share conversion.

Aristocrat Leisure Limited has announced an ordinary unfranked dividend of AUD 0.44 per share for the six months ending March 2025, with key dates set for May and July.

Enlitic Inc. has been reinstated to trading on the ASX following its announcement of a new equity raise, signaling renewed investor interest in the health technology firm.

HitIQ Limited's trading suspension has been lifted following its announcement of a proposed capital raising, signaling renewed investor interest and potential growth opportunities.

Eureka Group Holdings has upsized its debt facilities to $185 million with improved terms, enhancing its financial flexibility to expand residential developments across Australia.

McLaren Minerals Limited reported a challenging quarter with operating and investing cash outflows offset by a significant equity financing inflow, ending March 2025 with a modest cash balance and less than two quarters of funding runway.

Merino & Co reported a transformative quarter marked by operational upgrades, new product launches, and the integration of cryptocurrency payments, ending with a robust cash position to fuel future growth.

Vitasora Health Limited reports a striking 101% revenue increase and 57% patient growth in Q1 2025, driven by new Medicare Shared Savings Plan contracts and significant operational efficiencies from its Orb Health merger.